Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 3
This trial looked at a drug called denosumab and chemotherapy for non small cell cancer that had spread to another part of the body.
It was for people having their first treatment for non small cell lung cancer that had spread. Cancer that has spread is called advanced cancer.
This trial was open for people to join between 2015 and 2018. The team published the results in 2020.
Recruitment start: 22 July 2015
Recruitment end: 10 January 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sarah Danson
European Organisation for Research and Treatment of Cancer (EORTC)
European Thoracic Oncology Platform (ETOP)
NIHR Clinical Research Network: Cancer
Last reviewed: 20 June 2023
CRUK internal database number: 12601